Homocysteine: An independent risk factor for the failure of vascular intervention
- 1 September 1996
- journal article
- research article
- Published by Wiley in British Journal of Surgery
- Vol. 83 (9) , 1238-1241
- https://doi.org/10.1046/j.1365-2168.1996.02338.x
Abstract
No abstract availableKeywords
Funding Information
- Smith and Nephew Foundation
- South Western Regional Health Authority
This publication has 21 references indexed in Scilit:
- Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.Journal of Clinical Investigation, 1993
- Enhanced chemiluminescent assay for antioxidant capacity in biological fluidsAnalytica Chimica Acta, 1992
- Lipid peroxidation in homocysteinaemiaJournal of Inherited Metabolic Disease, 1992
- Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudicationJournal of Internal Medicine, 1992
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991
- Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease Effects of pyridoxine and folic acid treatmentAtherosclerosis, 1990
- Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.Journal of Clinical Investigation, 1986
- Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial DiseaseNew England Journal of Medicine, 1985